摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6H-dibenzo[b,f][1,5,2]dithiaazepine 5,5,11,11-tetraoxide | 1196988-06-3

中文名称
——
中文别名
——
英文名称
6H-dibenzo[b,f][1,5,2]dithiaazepine 5,5,11,11-tetraoxide
英文别名
6H-benzo[c][1,5,2]benzodithiazepine 5,5,11,11-tetraoxide
6H-dibenzo[b,f][1,5,2]dithiaazepine 5,5,11,11-tetraoxide化学式
CAS
1196988-06-3
化学式
C12H9NO4S2
mdl
——
分子量
295.34
InChiKey
ZNUKZYDJMXFBLF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    19
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    97.1
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Privileged structures: synthesis and structural investigations on tricyclic sulfonamides
    摘要:
    本文介绍了制备具有高度功能化自由磺酰胺三环结构的高效定制合成方法,这些结构在中央七元环内具有NH、O、S和SO2(Z组)。由于三环和磺酰胺基团在药物化学中的作用,也对这些分子的三维排列给予了关注。通过单晶X射线衍射和量子化学方法(HF-SCF/6-311+G(d,p))研究了它们的分子结构和构象性质。将固态中的最低能量几何结构(I, Z = O; II, Z = NH 和 III, Z = S, SO2)与气相中的最低能量几何结构(始终为III型几何结构)进行了比较,并根据文献参考值进行了讨论。努力将固态和气相中观察到的构象差异与Z组性质相关联。
    DOI:
    10.1039/b9nj00279k
点击查看最新优质反应信息

文献信息

  • [EN] TRICYCLIC SULTAM SULFONAMIDES AS ANTICANCER AND NEUROPROTECTIVE AGENTS<br/>[FR] SULFONAMIDES SULTAMES TRICYCLIQUES UTILISÉS EN TANT QU'AGENTS ANTICANCÉREUX ET NEUROPROTECTEURS
    申请人:ICAHN SCHOOL MED MOUNT SINAI
    公开号:WO2017044571A1
    公开(公告)日:2017-03-16
    A genus of arylsulfonamide derivatives of heterocyclic constrained tricyclic compounds is disclosed. The compounds are of the following genus : The compounds induce FOXO1 transcription factor translocation to the nucleus by modulating PP2A and, as a consequence, exhibit anti-proliferative effects. They are useful in the treatment of a variety of disorders, including as a therapy in cancer treatment, or used in combination with other drugs to restore sensitivity to chemotherapy where resistance has developed.
    揭示了一种杂环约束三环化合物的芳基磺酰胺衍生物的属。这些化合物属于以下属:这些化合物通过调节PP2A诱导FOXO1转录因子转位到细胞核,从而表现出抗增殖效果。它们在治疗各种疾病中很有用,包括作为癌症治疗中的一种疗法,或与其他药物结合以恢复对化疗的敏感性,尤其是当产生抗药性时。
  • 5,6-DIPHENYL-5,6-DIHYDRO-DIBENZ[C,E][1,2]AZAPHOSPHORIN AND 6-PHENYL-6H-DIBENZO[C,E][1,2]THIAZIN-5,5-DIOXIDE DERIVATIVES AND SIMILAR COMPOUNDS AS ORGANIC ELECTROLUMINESCENT MATERIALS FOR OLEDS
    申请人:Merck Patent GmbH
    公开号:US20220020934A1
    公开(公告)日:2022-01-20
    The present invention relates to 5,6-diphenyl-5,6-dihydrodibenz[c,e][1,2]azaphosphorin and 6-phenyl-6H-dibenzo[c,e][1,2]thiazine 5,5-dioxide derivatives and similar compounds of the formula (1) as organic electroluminescent materials for use in organic electroluminescent devices, for example in organic light-emitting diodes (OLEDs), where the symbols used are as follows: Z is the same or different at each instance and is PAr 2 or S(═O); E is the same or different at each instance and is O or S when the symbol Z to which this E binds is PAr 2 , and O when the symbol Z to which this E binds is S(═O); L is selected from the group consisting of a single bond, NAr 2 , O, S, S(═O) 2 , P(═O)Ar 2 , —X═X— and —C(═O)—NAr 2 ; the rest of the symbols are defined in the claims. The present invention discloses synthesis examples of inventive compounds, productions of OLEDs containing these example compounds, and results for these electroluminescent devices.
  • Privileged structures: synthesis and structural investigations on tricyclic sulfonamides
    作者:Maria Altamura、Valentina Fedi、Danilo Giannotti、Paola Paoli、Patrizia Rossi
    DOI:10.1039/b9nj00279k
    日期:——
    Customized synthetic procedures for the obtainment of highly functionalizable free sulfonamide tricyclic structures having NH, O, S and SO2 (Z group) in the central seven-membered ring are presented. Due to the role that tricycles and the sulfonamide group play in medicinal chemistry, attention have been also paid to the 3D arrangement of these molecules. Their molecular structures and conformational properties have been studied by single-crystal X-ray diffraction and quantum chemical methods (HF-SCF/6-311+G(d,p). The minimum energy geometries in the solid state (I, Z = O; II, Z = NH and III, Z = S, SO2) have been compared with the minimum-energy geometries in the gas phase (invariably the type III geometry) and discussed with respect to the literature reference values. An effort was made to correlate the conformational differences observed in the solid-state and gas-phase with the nature of the Z grouping.
    本文介绍了制备具有高度功能化自由磺酰胺三环结构的高效定制合成方法,这些结构在中央七元环内具有NH、O、S和SO2(Z组)。由于三环和磺酰胺基团在药物化学中的作用,也对这些分子的三维排列给予了关注。通过单晶X射线衍射和量子化学方法(HF-SCF/6-311+G(d,p))研究了它们的分子结构和构象性质。将固态中的最低能量几何结构(I, Z = O; II, Z = NH 和 III, Z = S, SO2)与气相中的最低能量几何结构(始终为III型几何结构)进行了比较,并根据文献参考值进行了讨论。努力将固态和气相中观察到的构象差异与Z组性质相关联。
查看更多

同类化合物

2,9-二(2-苯乙基)蒽并[2,1,9-DEF:6,5,10-D’E’F’]二异喹啉-1,3,8,10(2H,9H)-四酮 (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-盐酸沙丁胺醇 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3,3''-双([[1,1''-联苯]-4-基)-[1,1''-联萘]-2,2''-二醇 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3S,3aR)-2-(3-氯-4-氰基苯基)-3-环戊基-3,3a,4,5-四氢-2H-苯并[g]吲唑-7-羧酸 (3R,3’’R,4S,4’’S,11bS,11’’bS)-(+)-4,4’’-二叔丁基-4,4’’,5,5’’-四氢-3,3’’-联-3H-二萘酚[2,1-c:1’’,2’’-e]膦(S)-BINAPINE (3-三苯基甲氨基甲基)吡啶 (3-[(E)-1-氰基-2-乙氧基-2-hydroxyethenyl]-1-氧代-1H-茚-2-甲酰胺) (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-硝基苯基)磷酸三酰胺 (2-氯-6-羟基苯基)硼酸 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1α,1'R,4β)-4-甲氧基-5''-甲基-6'-[5-(1-丙炔基-1)-3-吡啶基]双螺[环己烷-1,2'-[2H]indene (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1R,1′R,2S,2′S)-2,2′-二叔丁基-2,3,2′,3′-四氢-1H,1′H-(1,1′)二异磷哚